Fetal Growth Restriction Management Guidelines

Diagnostic Criteria and Initial Evaluation

• The American College of Obstetricians and Gynecologists defines fetal growth restriction (FGR) as an estimated fetal weight or abdominal circumference below the 10th percentile on ultrasound, and management must be guided by gestational age at diagnosis, Doppler findings, and severity of growth restriction 1, 2
• FGR should be defined as estimated fetal weight or abdominal circumference <10th percentile using population-based references, ensuring consistent identification across clinical settings 2
• Perform a detailed anatomical ultrasound when FGR is diagnosed before 32 weeks gestation, as early-onset cases carry higher morbidity and mortality risk and require comprehensive structural assessment 1, 2
• Obtain umbilical artery Doppler assessment immediately upon FGR diagnosis to stratify risk and guide surveillance intensity, as this is the single most important prognostic tool for determining management 1, 2

Genetic and Infectious Workup

• Offer chromosomal microarray analysis when FGR occurs with fetal malformations, polyhydramnios, or both, regardless of gestational age, as these findings suggest underlying genetic abnormalities 1, 2
• Offer chromosomal microarray analysis for unexplained isolated FGR diagnosed before 32 weeks gestation, as early-onset isolated FGR has higher rates of chromosomal abnormalities 1, 2
• Do not routinely screen for toxoplasmosis, rubella, or herpes in FGR pregnancies without other risk factors, as these tests have low yield and are not cost-effective 1, 2
• Perform PCR testing for cytomegalovirus only in women with unexplained FGR who elect diagnostic amniocentesis, as CMV is the most common infectious cause of FGR worth investigating 1, 2

Prevention Strategies

• Do not use low-molecular-weight heparin solely for prevention of recurrent FGR, as evidence does not support this intervention 2
• Do not prescribe sildenafil or recommend activity restriction for in utero treatment of FGR, as these interventions are ineffective and potentially harmful 1, 2

Surveillance Protocol Based on Doppler Findings

• Perform weekly umbilical artery Doppler evaluation when end-diastolic velocity is decreased or when severe FGR is present, as this provides critical information for management decisions 1, 2
• Increase Doppler assessment frequency to 2-3 times per week for absent end-diastolic velocity, as this indicates significant placental dysfunction requiring heightened surveillance 1, 2
• Hospitalize immediately upon detection of reversed end-diastolic velocity, as this represents severe placental failure with imminent risk of fetal demise 1

Delivery Timing Algorithm

• The timing of delivery must balance the risks of prematurity against the risks of ongoing placental insufficiency, guided primarily by umbilical artery Doppler findings and severity of growth restriction 1, 2
• Deliver at 30-32 weeks for FGR with reversed end-diastolic velocity, as this represents the highest-risk category requiring earliest intervention 1
• Deliver at 33-34 weeks for FGR with absent end-diastolic velocity, as waiting beyond this gestational age increases stillbirth risk without meaningful reduction in neonatal morbidity 1
• Deliver at 37 weeks for FGR with decreased diastolic flow or severe FGR, as this balances the risks of prematurity and ongoing placental insufficiency 1

Mode of Delivery Considerations

• Consider cesarean delivery for FGR complicated by absent or reversed end-diastolic velocity based on the entire clinical scenario, as these fetuses have limited physiologic reserve and may not tolerate labor well 1

Antenatal Corticosteroids and Neuroprotection

• Administer antenatal corticosteroids if delivery is anticipated before 33 6/7 weeks gestation, as this is critical for reducing neonatal respiratory morbidity and mortality 1
• Administer intrapartum magnesium sulfate for fetal neuroprotection when delivery is anticipated before 32 weeks gestation, as this reduces the risk of cerebral palsy in surviving infants 1

Special Considerations for FGR with Oligohydramnios

• FGR complicated by oligohydramnios significantly worsens prognosis, indicating severe placental dysfunction 3
• At 35 weeks or beyond with FGR and oligohydramnios, proceed with immediate delivery after corticosteroid administration, as the risks of expectant management outweigh any benefits of continued gestation at this point 3

Critical Pitfalls to Avoid

• Do not delay delivery beyond recommended gestational ages based on Doppler findings, as this increases stillbirth risk 1
• Do not rely on biophysical profile or nonstress testing alone without Doppler assessment in diagnosed FGR, as Doppler provides superior prognostic information about placental function 1

Umbilical Artery Doppler–Guided Management of Intrauterine Growth Restriction (IUGR)

Definition and Initial Diagnosis

• IUGR is defined as an estimated fetal weight or abdominal circumference below the 10th percentile for gestational age using population‑based references such as the Hadlock formula. Society for Maternal‑Fetal Medicine (SMFM) guideline. 4

Surveillance Strategy (Umbilical Artery Doppler & Cardiotocography)

• Normal or decreased end‑diastolic velocity on umbilical artery Doppler warrants weekly Doppler assessment. SMFM guideline (Level I evidence). 4
• Absent end‑diastolic velocity requires Doppler evaluation 2–3 times per week to detect rapid deterioration. SMFM guideline. 4
• Reversed end‑diastolic velocity mandates immediate hospitalization, administration of antenatal corticosteroids, and cardiotocography (CTG) 1–2 times daily. SMFM guideline. 4
• Cardiotocography (NST/BPP) should be performed weekly after fetal viability when Doppler shows normal or decreased flow, and increased to twice weekly or more when Doppler shows absent or reversed flow or when additional maternal/fetal comorbidities are present. SMSM guideline. 4
• Middle cerebral artery, ductus venosus, and uterine artery Doppler are not recommended for routine clinical decision‑making because randomized trials have not demonstrated benefit. SMFM guideline (no RCT benefit). [4][5]

Delivery Timing Based on Doppler Findings

• Reversed end‑diastolic velocity → plan delivery at 30–32 weeks’ gestation. SMFM guideline. 4
• Absent end‑diastolic velocity → plan delivery at 33–34 weeks’ gestation. SMFM guideline. 4
• Decreased diastolic flow (still present) or severe IUGR (estimated fetal weight < 3rd percentile) → plan delivery at 37 weeks’ gestation. SMFM guideline. 4

Interventions to Avoid

• Low‑molecular‑weight heparin for prevention of recurrent IUGR is not supported by evidence and should be avoided. SMFM guideline. 4
• Sildenafil for in‑utero treatment of IUGR lacks efficacy data and should not be used. SMFM guideline. 4
• Activity restriction (e.g., bed rest) provides no benefit and may cause harm; it should be avoided. SMFM guideline. 4

Placental Insufficiency and Prognostic Indicators in Severe Asymmetric Fetal Growth Restriction

Etiology of Asymmetric FGR

• In cases of severe asymmetric fetal growth restriction where the abdominal circumference is below the 3rd percentile, the underlying cause is most often placental insufficiency, leading to preferential cerebral blood flow at the expense of liver glycogen stores and abdominal growth. 6

Impact of Amniotic Fluid Volume

• The presence of oligohydramnios together with severe asymmetric fetal growth restriction markedly worsens prognosis and signals severe placental dysfunction. 6